Exxonmobil Investment Management Inc. TX Has $2.58 Million Holdings in Laboratory Corp. of America Holdings (LH)

Exxonmobil Investment Management Inc. TX lowered its holdings in shares of Laboratory Corp. of America Holdings (NYSE:LH) by 12.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,187 shares of the medical research company’s stock after selling 2,403 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Laboratory Corp. of America were worth $2,582,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Valeo Financial Advisors LLC acquired a new stake in shares of Laboratory Corp. of America in the 3rd quarter worth $444,000. Cubist Systematic Strategies LLC lifted its stake in shares of Laboratory Corp. of America by 233.1% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 10,599 shares of the medical research company’s stock worth $1,600,000 after acquiring an additional 7,417 shares during the period. Tocqueville Asset Management L.P. lifted its stake in shares of Laboratory Corp. of America by 1,906.0% in the 3rd quarter. Tocqueville Asset Management L.P. now owns 32,677 shares of the medical research company’s stock worth $4,933,000 after acquiring an additional 31,048 shares during the period. PNC Financial Services Group Inc. lifted its stake in shares of Laboratory Corp. of America by 2.3% in the 2nd quarter. PNC Financial Services Group Inc. now owns 39,891 shares of the medical research company’s stock worth $6,150,000 after acquiring an additional 881 shares during the period. Finally, Calamos Advisors LLC lifted its stake in shares of Laboratory Corp. of America by 21.2% in the 3rd quarter. Calamos Advisors LLC now owns 171,866 shares of the medical research company’s stock worth $25,947,000 after acquiring an additional 30,017 shares during the period. Hedge funds and other institutional investors own 90.87% of the company’s stock.

Shares of Laboratory Corp. of America Holdings (NYSE:LH) traded down $6.44 on Monday, hitting $163.22. 903,247 shares of the stock were exchanged, compared to its average volume of 528,128. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.89 and a quick ratio of 1.75. The stock has a market cap of $16,720.00, a P/E ratio of 22.76, a PEG ratio of 1.61 and a beta of 0.92. Laboratory Corp. of America Holdings has a 1-year low of $128.00 and a 1-year high of $181.71.

Several analysts have recently commented on the stock. ValuEngine cut shares of Laboratory Corp. of America from a “buy” rating to a “hold” rating in a research note on Wednesday, January 10th. SunTrust Banks restated a “buy” rating and issued a $190.00 target price on shares of Laboratory Corp. of America in a research note on Thursday, October 12th. Goldman Sachs Group assumed coverage on shares of Laboratory Corp. of America in a research note on Monday, January 29th. They issued a “buy” rating and a $205.00 target price for the company. Robert W. Baird restated a “hold” rating and issued a $150.00 target price on shares of Laboratory Corp. of America in a research note on Friday, October 27th. Finally, Evercore ISI began coverage on shares of Laboratory Corp. of America in a research note on Thursday, January 4th. They issued an “outperform” rating and a $176.00 target price for the company. Six research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $175.00.

TRADEMARK VIOLATION WARNING: This report was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/05/exxonmobil-investment-management-inc-tx-decreases-stake-in-laboratory-corp-of-america-holdings-lh.html.

Laboratory Corp. of America Profile

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

Institutional Ownership by Quarter for Laboratory Corp. of America (NYSE:LH)

Receive News & Ratings for Laboratory Corp. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corp. of America and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply